Seneca Therapeutics

Blue Bell, PA · Founded 2018 · Privately Held (backing)

Developer of cell-based therapies designed to offer therapeutics and vaccines for solid cancer. Seneca Therapeutics is based in Blue Bell, PA and was founded in 2018. It was valued at $51 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $25.2 million across 5 recorded rounds; the latest was a $1.6 million seed round in Dec 2024.

PMV mark · valuation
$51.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$25.2M
Last round
Seed Round
Dec 2024
What is Seneca Therapeutics worth?
$51.0MPrivateMarketView mark · Oct 2026

Valued at $51.0M at its later-stage round, Jul 2025. Nothing has traded since.

Free account
More of Seneca Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Seneca Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Seneca Therapeutics funding history

5 rounds
DateRoundRaisedPost-money
Dec 2024Seed Round$1.6M▮
Mar 2021Early Stage VC$7.7M▮
Jun 2020Seed Round$501K▮
Nov 2019Seed Round$820K▮
May 2019Seed Round$380K▮
Unlock post-money valuations

Membership and data by Private Market View

Seneca Therapeutics valuation

Seneca Therapeutics was valued at $51 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Seneca Therapeutics raised?

Seneca Therapeutics has raised $25.2 million in total; 5 of its rounds are on record, from 2019 on. The largest on record was an $820,000 seed round in Nov 2019; the most recent was a $1.6 million seed round in Dec 2024.

Seneca Therapeutics has filed 9 Form Ds with the SEC since 2019, most recently in Feb 2025 ($1.6 million sold to 68 investors).

How Seneca Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Seneca Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Seneca Therapeutics

What is Seneca Therapeutics worth?
Seneca Therapeutics is valued at $51.0M as of Oct 2026. Valued at $51.0M at its later-stage round, Jul 2025. Nothing has traded since.
How much has Seneca Therapeutics raised?
Seneca Therapeutics has raised $25.2M in total funding across 5 recorded rounds.
When did Seneca Therapeutics last raise?
Seneca Therapeutics last raised in Dec 2024 (Seed Round), raising $1.6M.